[ Back ]   [ More News ]   [ Home ]
Cimatron's Q1/2011 Revenues up 12.3% YOY, non-GAAP Operating Profit up 370%

Declares dividend of NIS 0.45 (approximately US$0.13) per share

GIVAT SHMUEL, Israel, May 11, 2011 — (PRNewswire) — Cimatron Limited (NASDAQ and TASE: CIMT) , a leading provider of integrated CAD/CAM software solutions for the tool making and manufacturing industries, today announced financial results for the first quarter of 2011.

Q1/2011 Financial highlights

- New licenses revenue up 24% year-over-year on a constant currency basis

- Recurring maintenance revenue represents 50% of total revenue, increased 5% year-over-year on a constant currency basis

- $0.8M non-GAAP net profit

- $1.3 million positive cash flow from operating activities, a 94% year- over-year increase

- $13.0M cash balance at end of March 2011

The board of directors of Cimatron today declared a special cash dividend of NIS 0.45 (approximately US$0.13) per share on outstanding ordinary shares, representing a total dividend payment of approximately $1.2 million.

The dividend is payable on June 20, 2011 to shareholders of record at the close of business on May 31, 2011.

Commenting on the results, Danny Haran, President and Chief Executive Officer of Cimatron, said "We are very pleased with the first quarter results, and the continued momentum in our business. We are pleased with both new license sales as well as the growth in our recurring maintenance revenues. With the strong cash flow and solid cash balance, we are also pleased to announce our first cash dividend since 1999. We remain confident with respect to the remainder of 2011, where we expect the upcoming versions of CimatronE and GibbsCAM and the NC SuperBox to further boost sales", concluded Mr. Haran.

The following provides details on Cimatron's GAAP and non-GAAP results for the first quarter of 2011:

GAAP:

Revenues for the first quarter of 2011 increased 12.3% to $8.9 million, compared to $7.9 million recorded in the first quarter of 2010.

Gross Profit for the first quarter of 2011 was $7.5 million, as compared to $6.7 million in the same period in 2010. Gross margin in the first quarter of 2011 was 85% of revenues, compared to a gross margin of 84% in the same quarter of 2010.

Operating profit in the first quarter of 2011 was $0.4 million, compared to an operating loss of $(0.1) million in the first quarter of 2010.

Net Profit for the first quarter of 2011 was $0.3 million, or $0.04 per diluted share, compared to a net loss of $(0.1) million, or $(0.01) per diluted share, recorded in the same quarter of 2010.

Non-GAAP:

Revenues for the first quarter of 2011 increased 12.3% to $8.9 million, compared to $7.9 million recorded in the first quarter of 2010.

Gross Profit for the first quarter of 2011 was $7.7 million, as compared to $6.8 million in the same period in 2010. Gross margin in the first quarter of 2011 was 87% of revenues, compared to a gross margin of 86% in the same quarter of 2010.

Operating Profit in the first quarter of 2011 was $0.7 million, compared to an operating profit of $0.1 million in the first quarter of 2010, an increase of 370%.

Net profit for the first quarter of 2011 increased to $0.8 million, or $0.08 per diluted share, compared to a net profit of $0.1 million, or $0.01 per diluted share, recorded in the same quarter of 2010.

Conference Call

Cimatron's management will host a conference call today, May 12th, 2011 at 9:00 EST, 16:00 Israel time. On the call, management will review and discuss the results, and will answer questions by investors.

To participate, please call one of the following teleconferencing numbers. Please begin placing your call at least 5 minutes before the conference call commences.

                              USA: +1-888-407-2553
                          International: +972-3-9180610
                               Israel: 03-9180610

For those unable to listen to the live call, a replay of the call will be available from the day after the call at the investor relations section of Cimatron's website, at: www.cimatron.com

Reconciliation between results on a GAAP and Non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income included herein. Non-GAAP financial measures consist of GAAP financial measures adjusted to include recognition of deferred revenues of acquired companies and to exclude amortization of acquired intangible assets and deferred income tax, as well as certain business combination accounting entries. The purpose of such adjustments is to give an indication of our performance exclusive of non-cash charges and other items that are considered by management to be outside of our core operating results. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP.

Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. We believe that these non-GAAP measures help investors to understand our current and future operating performance, especially as our two most recent acquisitions have resulted in amortization and non-cash items that have had a material impact on our GAAP results. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies.

About Cimatron

With over 28 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM software solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles and ultimately shorten product delivery time.

The Cimatron product line includes the CimatronE and GibbsCAM brands with software solutions for mold design, die design, electrode design, 2.5 to 5 Axis milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.

Cimatron's shares are publicly traded on the NASDAQ exchange and the TASE under the symbol CIMT. For more information, please visit Cimatron's web site at: http://www.cimatron.com

Safe Harbor Statement

This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to Cimatron's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Cimatron's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycles, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron's business, refer to Cimatron's filings with the Securities and Exchange Commission. Cimatron cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

                                        CIMATRON LIMITED
                               CONSOLIDATED STATEMENTS OF INCOME
                      (US Dollars in thousands, except for per share data)

                                                          Three months ended
                                                               March 31,
                                                        2011           2010
    Total revenue                                       8,894         7,917
    Total cost of revenue                               1,345         1,251
    Gross profit                                        7,549         6,666
    Research and development expenses, net              1,554         1,485
    Selling, general and administrative expenses        5,571         5,284
    Operating income (loss)                               424          (103)
    Financial income (expenses), net                      116           (52)
    Taxes on income                                      (227)           57
    Other                                                  (2)            1
    Net income (loss)                                     311           (97)
    Less: Net (income) loss attributable
    to the noncontrolling interest                         28            (3)
    Net income (loss) attributable to
    Cimatron's shareholders                             $ 339        $ (100)
    Net income (loss) per share - basic and diluted    $ 0.04       $ (0.01)
    Weighted average number of shares outstanding
    Basic EPS (in thousands)                            9,106         9,078
    Diluted EPS (in thousands)                          9,239         9,078





                           CIMATRON LIMITED
            RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION
            (US Dollars in thousands, except for per share data)
                          Three months ended
                                  March 31,
                         2011                                      2010
    GAAP               Adj.       NON-GAAP       GAAP       Adj.    NON-GAAP

    Total revenue     8,894          -          8,894     7,917    -   7,917
    Total cost
    of revenue (1)    1,345       (147)         1,198     1,251 (147)  1,104
    Gross profit      7,549        147          7,696     6,666  147   6,813
    Research and
    Development
    expenses, net     1,554          -          1,554     1,485    -   1,485
    Selling, general
    and administrative
    expenses (1)      5,571       (101)         5,470     5,284  (99)  5,185
    Operating income
    (loss)              424        248            672      (103) 246     143
    Financial income
    (expenses), net     116          -            116       (52)   -     (52)
    Taxes on income (2)(227)       172            (55)       57  (91)    (34)
    Other                (2)         -             (2)        1    -       1
    Net income (loss)   311        420            731       (97) 155      58
    Less: Net (income)
    loss attributable
    to the
    noncontrolling
    interest             28          -             28        (3)   -      (3)
    Net income (loss)
    attributable to
    Cimatron's
    shareholders      $ 339      $ 420          $ 759    $ (100)$155     $55
    Net income (loss)
    per share - basic
    and diluted      $ 0.04                    $ 0.08   $ (0.01)      $ 0.01
    Weighted average
    number of shares
    outstanding
    Basic EPS
    (in thousands)    9,106                     9,106     9,078        9,078
    Diluted EPS
    (in thousands)    9,239                     9,239     9,078        9,078

    (1) Non-GAAP adjustment to exclude non-cash amortization of acquired
        intangible assets.
    (2) Non-GAAP adjustment to exclude the effect of deferred taxes.





                           CIMATRON LIMITED
                     CONSOLIDATED BALANCE SHEETS
                    (US Dollars in thousands)
                                              March 31,     December 31,
                                                2011            2010
                                                      ASSETS
    CURRENT ASSETS:
    Total cash, cash equivalents and
    short-term investments                   $ 12,980      $ 10,221
    Trade receivables                           5,990         5,708
    Other current assets                        2,429         2,275
    Total current assets                       21,399        18,204
    Deposits with insurance companies
    and severance pay fund                      3,299         3,279
    Net property and equipment                    896           949
    Total other assets                         12,469        12,469
    Total assets                             $ 38,063      $ 34,901
    LIABILITIES AND SHAREHOLDERS' EQUITY
    CURRENT LIABILITIES:
    Short-term bank credit                      $ 580          $ 99
    Trade payables                              1,245         1,685
    Accrued expenses and other liabilities      7,151         8,260
    Deferred revenues                           5,028         2,275
    Total current liabilities                  14,004        12,319
    LONG-TERM LIABILITIES:
    Accrued severance pay                       4,346         4,297
    Long-term loan                                105            98
    Deferred tax liability                        911         1,002
    Total long-term liabilities                 5,362         5,397
    Total shareholders' equity                 18,697        17,185
    Total liabilities and
    shareholders' equity                     $ 38,063      $ 34,901





                              CIMATRON LIMITED
                   STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
                            (US Dollars in thousands)

                                Accumulated
                                 other
                               comprehensive                   Comprehensive
                                income (loss)                  income (loss)
                                              Retained
                         Additional            earnings                 Total
    Noncontrolling  Share paid-in          (accumulated Treasuryshareholders'
    Interest       capital  capital          deficit)    stock        equity

    Balance at
    December 31,
    2010        $(74)   $304  $18,275 $(265) $(303) $(752)            $17,185
    Changes
    during the
    three months
    ended March
    31, 2011:
    Net income
    (loss)        (28)                                  339          311  311
    Exercise of
    share options          9      719                                     728
    Unrealized
    income on
    derivative
    instruments                          45                           45   45
    Other                               249                          249  249
    Foreign
    currency
    translation
    adjustment                          179                          179  179
    Total                                                            784
    comprehensive
    income
    Balance at
    March 31,
    2011        $(102)  $313  $18,994  $208    $36    $(752)          $18,697





                                         CIMATRON LIMITED
                                     STATEMENTS OF CASH FLOWS
                                     (US Dollars in thousands)
                                            Three months
                                                ended
                                              March 31,
                                           2011        2010

    Cash flows from operating activities:
    Net income (loss)                   $ 311       $ (97)
    Adjustments to reconcile net
    income (loss) to net cash provided
    by operating activities:
    Depreciation and amortization         375         387
    Increase (decrease) in
    accrued severance pay                  (8)         60
    Stock option compensation              15
    Deferred taxes, net                   170         (56)
    Changes in assets and liabilities:
    Increase in accounts receivable and
    prepaid expenses                     (282)     (1,675)
    Decrease in inventory                  17          11
    Increase in deposits with
    insurance companies and severance
    pay fund                              (20)        (64)
    Increase in trade payables,
    accrued expenses and other
    liabilities                           715       2,078
    Net cash provided by operating
    activities                          1,278         659
    Cash flows from investing activities:
    Purchase of property and equipment    (45)        (24)
    Net cash used in investing activities (45)        (24)
    Cash flows from financing activities:
    Short-term bank credit                456         541
    Long-term bank credit                   -          (8)
    Proceeds from issuance of shares
    upon exercise of options              728          11
    Investment in treasury stock            -         (84)
    Net cash provided by
    financing activities                1,184         460
    Net increase in cash and
    cash equivalents                    2,417       1,095
    Effect of exchange rate
    changes on cash                       342        (321)
    Cash and cash equivalents
    at beginning of period             10,221       6,684
    Cash and cash equivalents
    at end of period                  $12,980      $7,458
    Appendix A - Non-cash transactions
    Purchase of property on credit        $ 6         $ -



    Contact:
    Ilan Erez, Chief Financial Officer
    Cimatron Ltd.
    Tel: +972-73-237-0114
    E-mail: ilane@cimatron.com

SOURCE Cimatron Ltd

Contact:
Cimatron Ltd
.